主要还是其对原株及变异株的有效性和相对低的副作用。另外，有迅速更新的潜能，以对付更糟的变异株。第三针在测试中

来源: fuz 于 2021-03-13 18:22:53 [] [博客] [旧帖] [给我悄悄话] 本文已被阅读： 次 (19039 bytes)
本文内容已被 [ fuz ] 在 2021-03-13 19:03:02 编辑过。如有问题，请报告版主或论坛管理删除.

Pfizer-BioNTech vaccine may neutralize Brazil variant, lab study

https://www.washingtonpost.com/nation/2021/03/09/coronavirus-covid-live-updates-us/


Why Pfizer thinks a booster of its Covid vaccine might work against new variants
https://www.statnews.com/2021/02/25/is-more-simply-better-why-pfizer-thinks-a-booster-of-its-covid-vaccine-might-work-against-new-variants/

 

how well COVID-19 vaccines work against the 3 most worrisome coronavirus variants 
https://www.businessinsider.com/covid-19-vaccines-efficacy-variants-south-africa-uk-brazil-2021-3

Once a slew of mutations makes a particular strain better at infecting people, deadlier, or more able to evade the antibodies generated from a vaccination or a previous infection, geneticists label it a variant of concern.

There are three of these: B.1.1.7, the variant initially spotted in the UK in September; P.1, which was discovered in December; and B.1.351, which was detected in samples from South Africa dating back to October.

 

  ORIGINAL VIRUS B.1.1.7 B.1.351 P.1
Pfizer-BioNTech 95% Same efficacy Reduced antibody levels Same efficacy
Moderna 94% Same efficacy Reduced antibody levels More data needed
J&J 72%* Same efficacy Reduced efficacy
(in South Africa trials)		 Reduced efficacy
(in Latin America trials)
AstraZeneca 60-90% Same efficacy Reduced efficacy Same efficacy
Sinovac 50% Same efficacy Reduced antibody levels Reduced antibody levels
Note: *In US trials. Average of 66% efficacy with South Africa and Latin America trials included.

所有跟帖： 

• 我不会去追赶病毒变异，不会去打第 3 针...... N 针。 -法眼- ♂ 给 法眼 发送悄悄话 (0 bytes) () 03/13/2021 postreply 18:53:35

• 在老年人中，仍诱导出足够的抗体；对少年（12-16岁）也安全、有效；许多孕妇也打了。 -fuz- ♂ 给 fuz 发送悄悄话 fuz 的博客首页 (0 bytes) () 03/13/2021 postreply 18:58:40

请您先登陆，再发跟帖！